glp 1 and acid reflux Heartburn on GLP-1s: A Guide to Foods to Eat Avoid Molly Pelletier, Gut Health Dietitian

While this has increased the demand for products that are rich in fiber and protein but low in sugar and carbs, many traditional formulations contain ingredients like gluten or whey protein, making them off limits for individuals following plant-based diets or living with conditions like celiac disease

Endocrinology 153(2):647658

As a result, this approach works best when combined with lifestyle changes like diet and physical activity

#BMS #Cobenfy #Schizophrenia #Neuroscience #Psychiatry #PharmaNews #DrugDevelopment #Opdivo #Camzyos #AlzheimersDisease #Innovation #Healthcare #Biopharma To view or add a comment, sign in Market Watch | Bristol Myers Squibbs Cobenfy Faces Uptake Challenges Amid Strong Q3 Earnings Bristol Myers Squibb ($BMY) reported $12.2B in Q3 revenue, surpassing analyst expectations yet investor attention centered on Cobenfy, the first new schizophrenia drug in 35 years, which posted $43M in sales, slightly below forecasts

Results Study population characteristics A total of 417,322 patients with AKI who required dialysis were discharged from the hospital

Supply Shortages: Due to increased demand, theres been a shortage of semaglutide injection products (Ozempic and Wegovy) since 2022